Skip to main content
. 2016 Aug 22;7(38):61970–61987. doi: 10.18632/oncotarget.11486

Table 3. Genotypes significantly associated with increased relative risk to develop osteosarcoma compared to healthy controls identified by logistic regression analysis.

Polymorphism [risk-associated genotype] OR (CI 95%) p
ABCC2_1249A/G [HET + VAR] 1.71 (1.20–2.43) 0.003
ABCC2_3972A/G [VAR] 2.24 (1.18–4.24) 0.013
hMLH1_676A/G [HET + VAR] 1.62 (1.14–2.31) 0.007
XPG_3508G/C [VAR] 2.47 (1.36–4.50) 0.003
GGH_401T/C [VAR] 2.14 (1.07–4.69) 0.032
GGH_16T/C [VAR] 2.24 (1.07–4.69) 0.033
MTHFR_677T/C [VAR] 1.68 (1.08–2.61) 0.022
TYMS_28bp_VNTR [HET + VAR] 1.67 (1.18–2.35) 0.004
MDM2_309T/G [HET + VAR] 1.73 (1.22–2.46) 0.002
[VAR] 2.25 (1.46–3.47) < 0.001
TP53_IVS2 + 38G/C [HET + VAR] 13.37 (7.76–23.03) < 0.0001
[VAR] 15.63 (10.20–24.39) < 0.0001
TP53_ex4 + 119G/C [WT] 1.68 (1.17–2.41) 0.005

OR, odd ratio; CI, confidence interval; p values refer to the genotype with higher risk which is given in brackets; WT, wild-type; HET, heterozygous; VAR, variant.